Stockreport

Pliant Therapeutics to Participate in the Oppenheimer Healthcare Life Science Conference

Pliant Therapeutics, Inc.  (PLRX) 
PDF SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discover [Read more]